Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

ALBUTEROL INHALATIO

Active
SPE2DP-26-T-4470Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Albuterol Inhalation Aerosol is a prescription-only medication supplied as a pressurized aluminum canister containing 60 actuations, each delivering 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, through a plastic actuator with a strap cap and built-in counter. The canister has a net weight of 8 grams and must be stored at 20° to 25°C (68° to 77°F), with allowable excursions between 15° and 30°C, following USP controlled room temperature guidelines. The inhaler must be kept with the mouthpiece down, shaken well before each use, and brought to room temperature prior to administration to ensure optimal performance. The product has a non-extendable shelf life of 18 months, and at the time of receipt by the first government activity, a minimum of 15 months of shelf life must remain. It is labeled and marked in compliance with SPE2DP-26-T-4470 and Medical Marking Standard No. 1C, and is classified as a hazardous material with flammable characteristics due to its pressurized contents. The canister must not be punctured, exposed to temperatures above 120°F, or disposed of in fire or incinerators. A current Material Safety Data Sheet (MSDS) is required and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL along with a completed cover sheet. Packaging must conform to 49 CFR and ICAO regulations for hazardous materials. The NSN is 6505-01-649-7928, with a quantity of 15 units ordered under Purchase Request 7017715897, with delivery required within 20 days of award. The solicitation is governed by DLA technical and quality requirements referenced in the DLA Master List, and buyers must confirm regulatory compliance through an EBS referral to the product specialist, providing manufacturer and bidder details. The item is regulated by the FDA and falls under Defense Information potentially subject to additional reporting.

General Info

Albuterol inhaler, 60 actuations, 90mcg base, flammable, 18-month shelf life, 15-month min remaining, hazardous, 20°C–25°C storage, 15 units, 20-day delivery.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

BLDG 7244 NIGHTSTALKER WAY, FORT CAMPBELL, KY, 42223-5000, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4470.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
DANIEL PORTER
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
ALBUTEROL INHALATIO
ALBUTEROL INHALATION AEROSOL
RX ONLY, FOR ORAL INHALATION ONLY.
INSTITUTIONAL PACK; CONTAINS 60 ACTUATIONS.
.
SUPPLIED AS A PRESSURIZED ALUMINUM CANISTER
FITTED WITH A COUNTER AND SUPPLIED WITH A
PLASTIC ACTUATOR WITH STRAPCAP.
.
STRENGTH: 90 MICROGRAMS (PER ACTUATION).
NET WEIGHT (OF THE CANISTER): 8 GRAMS
.
EACH ACTUATION DELIVERS108 MCG OF ALBUTEROL SULFATE
(90 MCG OF ALBUTEROL BASE) FROM THE MOUTHPIECE.
.
UNIT OF ISSUE IS EACH.
.
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
THERE SHALL BE A MINIMUM OF 15 MONTHS OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY. . STORE AT 20° TO 25°C (68° TO 77°F); EXCURSIONS PERMITTED TO 15 TO 30°C (59 TO 86°F) [SEE USP CONTROLLED ROOM TEMPERATURE] . STORE THE INHALER WITH THE MOUTHPIECE DOWN. FOR BEST RESULTS, THE INHALER SHOULD BE AT ROOM TEMPERATURE BEFORE USE. . SHAKE WELL BEFORE EACH SPRAY .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
CONTENTS UNDER PRESSURE: DO NOT PUNCTURE.
DO NOT USE OR STORE NEAR HEAT OR OPEN FLAME.
EXPOSURE TO TEMPERATURES ABOVE 120°F MAY CAUSE BURSTING.
NEVER THROW THE CANISTER INTO FIRE OR INCINERATOR.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
SPE2DP-26-T-4470
SECTION B
MEDICAL MARKING STANDARD NO. 1C
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . . ITEM HAS FLAMMABLE/COMBUSTIBLE CHARACTERISTICS. . . HAZARDOUS MATERIALS REQUIREMENTS. . MATERIAL SAFETY DATA SHEET (MSDS). .
. A CURRENT MSDS SHALL BE PROVIDED FOR THIS ITEM. DLA'S DOD HMIRS FOCAL POINT (VBA) HAS ESTABLISHED AN ELECTRONIC MAILBOX TO WHICH ONE CAN TRANSMIT THE MSDS, TOGETHER WITH THE COVER SHEET (P-75) WHOSE CONTENTS ARE TO REFLECT LOGISTICS INFORMATION PROPER TO THE MSDS ASSOCIATED WITH THE AWARDED CONTRACT AND NSN. THE ELECTRONIC MAILBOX ADDRESS IS DLA.MSDS@DLA.MIL. .
. IN ADDITION, A COPY OF THE MSDS SHALL ACCOMPANY EACH SHIPMENT OF THIS ITEM. . PACKAGING. .
. PACKAGING FOR HAZARDOUS MATERIALS SHALL COMPLY WITH APPLICABLE REGULATIONS, I.E., 49 CFR, INTERNATIONAL CIVIL AVIATION ORGANIZATION (ICAO) TECHNICAL NSN/Part Number: 6505-01-649-7928 Quantity: 15 EA Purchase Request: 7017715897QTY: 15 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
LIDOCAINE AND PRILOCAI
Solicitation # SPE2DP-26-T-4475
Lidocaine and prilocaine periodontal gel, marketed as ORAQIX at a 2.5%/2.5% concentration, is a microemulsion dental anesthetic supplied in individual blister-packed cartridges, each containing 1.7 grams of gel, with 20 cartridges per carton. Each cartridge comes with a single-use sterile blunt-tipped applicator and must be stored at controlled room temperature between 20°C and 25°C. The product is regulated by the FDA and classified as a prescription-only device with a non-extendable shelf life of 36 months, requiring labeling in compliance with MMS No. 1. Packaging must conform to DLA specifications, including MIL-STD-129 marking, and all technical and quality requirements from the DLA Master List take precedence over commercial standards. The item is identified by NSN 6505-01-656-9640 and manufacturer part number NDC66312-0110-20 from Dentsply Sirona Inc. The contract, issued under solicitation SPE2DP-26-T-4475, requires delivery of three packages to Seymour Johnson Air Force Base in North Carolina within 20 days of order placement, with FOB destination terms and zero tolerance for quantity variance. Shipping must be conducted via traceable means, explicitly prohibiting parcel post. The delivery is scheduled for August 5, 2026, and the contract includes federal acquisition compliance requirements, including referral protocols for FDA-regulated items through EBS and adherence to covered defense information protocols. The purchasing request number is 7017708438, and all packaging and unit of issue must align with DLA’s authorized standards, with point of contact Lawrence Garnett available for coordination.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-26-T-4479
The contract is for the procurement of a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed for outdoor use and meeting stringent military specifications. The product is sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. Each unit of issue consists of a package containing 24 tubes of 3 ounces each, with a total shelf life of 24 months and a minimum of 21 months remaining at the time of government receipt. Storage must occur between 15°C and 30°C in a cool, dry environment. The item is regulated by the FDA and classified as a Type I (Code M) item with a non-extendable shelf life. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection during transit. All packaging and labeling must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. The product must be shipped in commercial exterior containers suitable for safe delivery by common carrier via the fastest traceable means, with no use of parcel post permitted. Delivery is FOB destination with a 20-day lead time, and the sole delivery point is the USS ZUMWALT DDG 1000 at FPO AP 96693. The shipment must be palletized in accordance with DLA packaging requirements and labeled with the NSN 6505-01-657-9247 and contract line item number 7017729391. The order quantity is one package, and no variance in quantity is permitted. The procurement is issued under solicitation SPE2DP-26-T-4479, with a response deadline of August 10, 2026, and a required delivery date of August 6, 2026. Transportation and shipping protocols are governed by DLAD procedural notes C19 and C20, and all vendors must use the Vendor Shipping Module for tracking. The contracting office is part of the Department of Defense’s Medical Supply Chain, and any bid must be referred to the product specialist in EBS with manufacturer and item details for confirmation prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
SLED
Pharmacy Services for 340B Purchasing Program
Solicitation # RFP 26-19772-KM
The City of Lubbock is seeking qualified vendors to provide pharmacy services under its 340B Purchasing Program through Solicitation RFP026-19772-KM, which was posted on August 4, 2026, with proposals due by August 27, 2026. The contract aims to secure comprehensive pharmacy support that aligns with federal 340B eligibility requirements, ensuring cost-effective access to medications for eligible patients served by the city’s health programs. Vendors must demonstrate experience in 340B program compliance, drug procurement, inventory management, and reporting, with an emphasis on efficiency, transparency, and adherence to regulatory standards. All proposals must be submitted through the Texas SmartBuy portal, and inquiries should be directed to Kiara Morgan, the primary point of contact, or Marta Alvarez, Director of Purchasing, both reachable via email or phone at the listed numbers. The contract will be performed within Lubbock, Texas, and vendors are expected to work closely with the city’s healthcare providers to ensure seamless integration of pharmacy services into existing systems. The solicitation does not specify a set-aside type, making it open to all eligible vendors, and responses must fully address all technical, financial, and compliance requirements outlined in the proposal guidelines.
CITY OF LUBBOCK

POSTED

about 11 hours ago

DEADLINE

in 23 days
View Details
NAICS: 424210
New
Federal
Supply of Eco-Friendly Janitorial Consumables
Mrpbs Minneapolis Mn

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
Supplier of Medical Devices and Components (NSN-Based)This contract seeks suppliers to provide medical devices and components identified by National Stock Numbers for procurement by the Department of Defense. All items must meet strict technical specifications, packaging standards, labeling requirements, and shelf-life criteria to ensure operational readiness and compliance with military medical logistics protocols. The contract is structured as a subcontract under NAICS code 424210, focused on medical equipment and supplies distribution, and performance is designated to occur at APO 09227-0000, indicating delivery to U.S. military overseas locations. Responses are due by August 10, 2026, with the solicitation posted on August 3, 2026, through the DIBBS system, and no set-aside provisions are specified, meaning all eligible suppliers may compete.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
Small Business and Socioeconomic-Compliant SubcontractingThis contract opportunity is designed to support small, veteran-owned, HUBZone, women-owned, and service-disabled veteran-owned businesses by enabling them to serve as subcontractors on a larger procurement effort managed by the Defense Logistics Agency under the Department of Defense. The solicitation is tied to the NAICS code 424210, which corresponds to pharmaceutical and botanical product merchant wholesalers, indicating the primary scope of subcontracted goods or services involves the distribution of medical and pharmaceutical supplies. The initiative aims to fulfill federal socioeconomic goals by prioritizing participation from designated small business categories, ensuring equitable access to government contracting opportunities without a formal set-aside designation. Performance is expected to support defense logistics operations nationwide, with no specific location designated for performance. The contract was posted in August 2026 and is linked to an existing prime award, allowing qualified small businesses to align their capabilities with the prime contractor’s needs to meet diversity and inclusion targets within the defense supply chain.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 424210
New
DIBBS
Medical Kit Procurement and SupplyThe contract pertains to the procurement of the DIP QUICK STAIN KIT BULK REFILL, identified by NSN 6550-01-484-2014, for use in medical and surgical environments under the Department of Defense’s Medical Supply Chain. All suppliers must be FDA-approved and adhere strictly to established medical supply standards to ensure product safety, efficacy, and consistency. The kit is intended for bulk replenishment and must meet rigorous quality controls applicable to diagnostic reagents used in field and clinical settings. This is a subcontract under the NAICS code 424210, with a response deadline of August 10, 2026, and a posted date of August 3, 2026. The place of performance is listed as APO 09227-0000, indicating delivery to overseas or military locations. The agency responsible is the Medical Supply Chain MD Surg FSF, operating under the Department of Defense. The procurement is governed by federal acquisition protocols, and vendors must comply with all regulatory and logistical requirements for distributing medical consumables to defense facilities.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-26-T-4340
The contract specifies the procurement of sunscreen preparation with an SPF of 50, containing 4.5% titanium dioxide and 4% zinc oxide, designed for topical over-the-counter use. It is sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, biodegradable, and intended for outdoor use. The unit of issue is a package containing 24 three-ounce tubes, with a total shelf life of 24 months; a minimum of 21 months of remaining shelf life is required at time of delivery. Storage must be maintained between 15°C and 30°C (59°F to 86°F) in a cool, dry location. The item is regulated by the FDA and requires pre-award referral for product specialist confirmation. Packaging must comply with DLA Master List of Technical and Quality Requirements, which supersede ASTM D3951, and must adhere to Medical Marking Standard No. 1, replacing all references to MIL-STD-129. Palletization must follow RP001 requirements, and all packaging must be commercially sealed to prevent damage. Hazardous material handling, as defined by FED-STD-313, requires compliance with TQ Requirement IP025, while non-hazardous materials must meet ASTM D3951. Marking must include U/I and QUP as specified, and shipments must avoid parcel post, utilizing only traceable transportation methods. Deliveries are FOB destination with zero variance tolerance and inspection and acceptance occurring at the delivery point. Three distinct delivery locations are specified including military units in Massachusetts, North Carolina, and a ship FPO address, with delivery required within five days of award. The solicitation number is SPE2DP-26-T-4340, and responses are due by August 3, 2026. The contract includes compliance with a wide array of FAR and DFARS clauses covering electronic invoicing through WAWF, cybersecurity safeguards, prohibited substances like hexavalent chromium and covered defense telecommunications equipment, export controls, trafficking in persons, employment eligibility verification, sustainable products, and whistleblower protections. Offerors must represent their size status and socioeconomic certifications through SAM and disclose any use of covered telecommunications equipment. No pricing information is provided within the solicitation, and the contract type is not explicitly defined, though terms suggest a fixed-price arrangement under simplified acquisition procedures.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 1 day
View Details
NAICS: 424210
New
Federal
Notice of Intent to Award - Pharmaceutical medical/surgical products
Solicitation # IHS1523704
The Navajo Area Indian Health Service, through the Chinle Comprehensive Health Care Facility in Chinle, Arizona, intends to award a sole-source contract to McKesson Corporation for the supply of pharmaceutical medical and surgical products. The contract will have a base performance period of one year beginning on the date of award, with no further awards anticipated unless operational needs change. The acquisition is classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, with a small business size standard of 1,300 employees, though no set-aside is being applied. The government has determined that current conditions justify a single-award approach and is not seeking competitive bids at this time, but is inviting other potential suppliers to submit capability statements, price lists, and catalogs via email by August 10, 2026, at 5 p.m. MST, for future consideration. Responses will not constitute formal bids and will be used solely to evaluate the potential for future competitions; no proprietary, classified, or confidential information should be included. The government retains the right to use any non-proprietary technical information in subsequent solicitations, and any future competitive procurement will be publicly announced via Federal Business Opportunities. Inquiry and submission must be directed to Danelle Attson at the designated email and phone number, with the contracting office located in Rockville, Maryland, and performance to occur in Arizona.
Indian Health Service

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
Medical Product Distribution and Delivery to DestinationThe contract involves the logistics and delivery of boxed nasopharyngeal airways to a designated destination in accordance with Department of Defense standards, specifically requiring full compliance with DLA inspection and acceptance protocols. Execution of this subcontract is tied to the NAICS code 424210, indicating a focus on medical and surgical equipment distribution. The place of performance is listed as APO with ZIP code 96264-2022, signifying that delivery must be made to a military postal address, likely supporting overseas operations. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026, under the Medical Supply Chain MD SURG FSF organization within the Department of Defense. All deliveries must meet stringent quality and documentation requirements to ensure readiness and safety for use in medical environments. The nature of the product demands precise handling, packaging, and traceability throughout the supply chain, with inspections conducted by DLA authorities prior to acceptance. Although the point of contact and specific office details are not provided, the contract is accessible via the DIBBS platform, indicating it is managed through official DoD procurement channels. The subcontract aims to ensure timely and compliant supply of critical medical devices to authorized military locations without delay or deviation from federal standards.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
Pharmaceutical Supply Delivery – Promethazine Hydrochloride (NSN: 6505000654214)The contract obligates the supply and delivery of 1,000 kilograms of Promethazine Hydrochloride with National Stock Number 6505000654214 to the USS ZUMWALT DDG 1000 at a Fleet Post Office address. All shipments must adhere to strict DLA logistics protocols, ensuring full traceability from origin to final destination, with delivery terms specified as FOB destination. The product is classified under NAICS code 424210, indicating distribution within the pharmaceutical and cosmetic wholesale industry, and the contract is structured as a subcontract under the Defense Logistics Agency, a component of the Department of Defense. Compliance with all federal medical supply standards, handling requirements, and military receipt verification procedures is mandatory to fulfill the obligation.
Defense Logistics Agency

POSTED

2 days ago

DEADLINE

N/A
View Details
NAICS: 424210
New
DIBBS
Medical Supply Packaging and MarkingThe contract pertains to the packaging and marking of medical supplies in strict compliance with Department of Defense standards, specifically DLA and MIL-STD-129 requirements, ensuring all items are properly labeled for storage and destination. This includes accurate application of barcodes, unit identification codes, and other mandated markings to support logistics traceability and inventory management across military supply chains. The work must adhere to federal guidelines for durability, readability, and placement of labels to meet operational readiness standards. This is a subcontract under the NAICS code 424210, classified under the Medical Supply Chain MD Surg FSF organization within the Department of Defense. The solicitation was posted on August 2, 2026, with a response deadline of August 10, 2026, indicating a tight turnaround for qualified vendors to submit proposals. The place of performance details are not specified, suggesting the work may be performed at multiple locations or determined post-award. Interested parties must access the full solicitation through the DIBBS portal to understand technical specifications, delivery timelines, and compliance obligations detailed in the official documents.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
BUPIVACAINE AND EPINEP
Solicitation # SPE2DP-26-T-4478
The contract specifies the procurement of Bupivacaine and Epinephrine Injection, containing 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL (1:200,000), packaged in 1.8 mL cartridges, with a unit of issue of one case containing 50 cartridges. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and must have a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be commercially packaged to ensure safe transit under ASTM D3951 or applicable hazardous material standards if classified as hazardous under FED-STD-313. The supply must be free of intentional mercury or mercury compounds, except where functionally necessary and explicitly exempted, and any permitted mercury-containing components must meet Navy shockproof and secondary containment requirements. Delivery is required FOB destination within 20 days to the USS Delaware (SSN 791) at FPO AE 09583, with no variance allowed in quantity, and shipment must use traceable, expedited methods with no parcel post. The item is identified by NSN 6505-01-189-3973 and purchase request 7017729383, with a required delivery date of August 6, 2026. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, which supersedes any conflicting standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
VERAPAMIL HYDROCHLO
Solicitation # SPE2DP-26-T-4480
Verapamil Hydrochloride Extended-Release Tablets, 240 mg, are being procured in bottles of 100 tablets each, with a total quantity of two bottles required under contract SPE2DP-26-T-4480. The product must have a minimum of 31 months of shelf life remaining at the time of delivery, with a full 36-month shelf life specified and non-extendable. Packaging must comply strictly with DLA Packaging Requirements for Procurement and the latest Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection from damage during transit. All units must be commercially packaged in suitable exterior shipping containers, meeting the lowest freight rate standard for delivery to the specified destination. The item is regulated by the FDA, and the contracting official must confirm compliance via EBS referral. Manufacturer and distributor information includes Glenmark Pharmaceuticals Inc., USA and Cardinal Health 200, LLC, with the NDC number NDC68462-0260-01. The delivery is FOB destination, with a 20-day delivery window and no quantity variance permitted. Shipment must be traceable and cannot be sent via parcel post; instead, it must be transported using the FASTEST TRACEABLE MEANS with RDD 777 and referenced to the DLA vendor code V23027. The required delivery date is February 17, 2026, and the item is to be delivered to USS IWO JIMA LHD 7, FPO AA 34094. All packaging, labeling, and documentation must adhere to applicable DLA technical and quality requirements listed in the DLA Master List, which take precedence over ASTM D3951 and other commercial standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSE
Solicitation # SPE2DP-26-T-4477
Permectrin Cream Rinse is a 1% w/v topical medication packaged as a 2 fl oz plastic squeeze bottle, each unit including a comb for application, and supplied in individual units with a minimum of 21 months of remaining shelf life at time of receipt by the government, ensuring a 24-month total shelf life is maintained. The item is regulated by the FDA and must comply with all applicable medical, packaging, and hazardous materials standards including Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging requirements that ensure protection from damage during shipping and compliance with commercial standards for both interior and exterior containers. All shipments must include a current Safety Data Sheet (SDS) formatted per 29 C.F.R. 1910.1200, with labels meeting OSHA’s Hazard Communication Standard and the Globally Harmonized System, and these documents must be submitted for approval before contract award. Each shipment must also carry a copy of the SDS and be marked in accordance with the approved medical marking guidelines. The product is subject to DLA’s technical and quality requirements as outlined in the DLA Master List, and must comply with all applicable transportation regulations including 49 CFR and ICAO standards for hazardous materials. The NSN is 6505-01-256-4972, with two units requested under solicitation SPE2DP-26-T-4477, with a 20-day delivery requirement and a contract awarded to a government activity under the Department of Defense.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
GLOBULIN, RHO (D) IMMUN
Solicitation # SPE2DP-26-T-4482
GLOBULIN RHO (D) IMMUNE, USP, 300 MICROGRAMS per 1ML disposable syringe with safety mechanism, is intended for intramuscular injection only and is designated for adult use. The product must be stored at 2 to 8 degrees Celsius and must not be frozen. It is a prescription-only item and packaged individually as a single unit. The item is regulated by the FDA and requires confirmation through the EBS referral system, including submission of bidder and manufacturer details. The NSN is 6505-01-417-1250, and it is subject to DLA packaging and technical requirements referenced in the DLA Master List of Technical and Quality Requirements. As a hazardous material, it requires a current Material Safety Data Sheet (MSDS) to be submitted to DLA.MSDS@DLA.MIL and physically included with each shipment, with packaging compliant with 49 CFR and ICAO regulations. This solicitation, issued under SPE2DP-26-T-4482 by the Department of Defense’s Medical Supply Chain PHARM FSA, has a response deadline of August 10, 2026, with a delivery requirement of 20 days after award. The point of contact for inquiries is James Foggie, with email and phone provided for coordination.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
APPLICATOR, SILVER NITR
Solicitation # SPE2DP-26-T-4469
The applicator consists of a 75% silver nitrate and 25% potassium nitrate mixture fused to one end, measuring six inches or 1.524 centimeters, and is intended for topical use only with a prescription requirement. Each unit of issue is a container holding 100 applicators, which must be stored in the original closed package at room temperature in a dark, dry location, away from organic or oxidizable materials. The item is classified as a Type I (Code M) shelf-life item with a non-extendable shelf life of 24 months. It is regulated by the FDA, and buyers must submit a referral in EBS to confirm product details including bidder and manufacturer information. Hazardous materials regulations apply, requiring a current MSDS to be submitted via DLA.MSDS@DLA.MIL and included with each shipment, with packaging compliant to SPE2DP-26-T-4469 and applicable 49 CFR and ICAO standards. Removal of government identification from non-accepted supplies is required, and covered defense information potentially applies. The NSN is 6505-00-299-9672, with a single contract order quantity and a 10-day delivery requirement after award. The solicitation, issued under SPE2DP-26-T-4469, was posted on August 4, 2026, with responses due by August 10, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Nicholas Quigley listed as the primary point of contact.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
HYDROGEN PEROXIDE TOPI
Solicitation # SPE2DP-26-T-4481
Hydrogen Peroxide Topical Solution USP RP001 is a 3% stabilized solution intended for external topical use only, not for ingestion or application to the eyes or large body areas, and must not be used for more than one week. Each unit of issue is a 473-milliliter bottle, requiring tight closure, storage at controlled room temperature, protection from freezing and excessive heat, and must not be shaken. Labeling and packaging must strictly comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and all packaging must be commercially sealed and designed to prevent damage during transport. The item is regulated by the FDA and classified as a TYPE I (CODE M) item with a non-extendable shelf life of 24 months. As a hazardous material under OSHA’s revised Hazard Communication Standard effective June 1, 2015, suppliers must provide Safety Data Sheets (SDS) and compliant HCS labels per 29 C.F.R. 1910.1200, and must train employees on these requirements. The contract mandates delivery within 20 days to FPO AP 96693, FOB destination, with zero variance in quantity, and prohibits parcel post in favor of traceable shipping methods. The NSN is 6505-00-153-8480, with a contracted quantity of two bottles, procured under solicitation SPE2DP-26-T-4481, and all technical and quality requirements are governed by the DLA Master List, which supersedes ASTM D3951. Approved manufacturers include Medline Industries, LP, Cardinal Health 200, LLC, and McKesson Medical-Surgical Government, with the item identified by multiple NDC and part numbers. All deliveries must be palletized per RP001 requirements and marked per Medical Marking Standard No. 1.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
CALCIUM CHLORIDE INJEC
Solicitation # SPE2DP-26-T-4471
CALCIUM CHLORIDE INJECTION USP is procured as a 10 mL single-dose plastic syringe containing 1 gram of calcium chloride (100 mg/mL), packaged ten syringes per unit (1 PG = 10 EA), with a mandatory 24-month shelf life from the date of manufacture, no less than 21 months of which must remain at the time of delivery to the government. The product must be labeled in strict accordance with Medical Marking Standard No. 1, including the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number, and stored at 20 to 25°C (68 to 77°F). The item is regulated by the FDA and requires prior confirmation from the product specialist via EBS referral before award. Packaging must be commercial and designed to protect against damage, with exterior shipping containers ensuring safe, cost-effective transport to the delivery point. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The manufacturer is Pfizer Inc, with NDC 00409-1631-10, and the item is identified by NSN 6505-01-655-0700. Delivery is FOB destination in 20 days to Fort Campbell, Kentucky, with zero quantity variance permitted, and shipment must occur via traceable means, excluding parcel post. The contract reference is SPE2DP-26-T-4471, with an original required delivery date of August 5, 2026, and procurement governed by the DLA Master List of Technical and Quality Requirements, which take precedence over all other standards including ASTM D3951.
Medicinal and Botanical Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, U
Solicitation # SPE2DP-26-T-4483
The contract specifies the procurement of 6 units of TOLNAFTATE POWDER, USP 1%, each unit being 45 grams, for delivery to a U.S. military vessel at FPO AP 96693. The item, identified by NSN 6505-01-480-7897 and NDC 57896-0199-45, must comply with stringent packaging and labeling requirements, including adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be commercially packaged in accordance with ASTM D3951 unless specified otherwise by DLA Master List requirements. The product has a non-extendable shelf life of 36 months and must be labeled and marked according to federal medical standards. Delivery is due within 20 days of contract award, with a firm fixed price and zero variance allowed in quantity. Freight must be shipped via the fastest traceable means—parcel post is prohibited—and transportation must follow DLA Procurement Notes C19 and C20. The contract requires FOB destination delivery, with inspection and acceptance occurring at the final destination. All packaging and palletization must conform to DLA Packaging Requirements for Procurement, and the supplier, GERI-CARE PHARMACEUTICALS CORP., must ensure compliance with all technical and quality specifications outlined in the DLA Master List. The solicitation was issued on August 4, 2026, with a response deadline of August 10, 2026, under contract number SPE2DP-26-T-4483.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4472
Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, designed for rectal administration and external use only. It is supplied in a collapsible tube and includes a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of ointment. The product must be stored at temperatures between 15 and 30 degrees Celsius or 59 to 86 degrees Fahrenheit to maintain stability and efficacy. This item has a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of the Medical Marking Standard No. 1. It is regulated by the FDA and classified as a Type I (Code Q) pharmaceutical item with specific supply chain requirements under DLA standards. The contract, issued under solicitation number SPE2DP-26-T-4472, requires delivery of five packages (PG) to be shipped FOB destination within ten days. The quantity variance is strictly zero percent, meaning exact fulfillment is mandatory. Inspection and acceptance occur at the destination, and packaging must comply with MIL-STD-2073-1E. The NSN is 6505-00-299-9535 and the manufacturer part number is NDC00536-1211-95, supplied by The Harvard Drug Group, L.L.C. All procurement activities are governed by DLA technical and quality requirements referenced in the DLA Master List, and the contracting official must submit an EBS referral to confirm regulatory compliance before award. The point of contact for the solicitation is Alec Deichman, and the place of performance is San Antonio, Texas.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
MOXIFLOXACIN HYDROC
Solicitation # SPE2DP-26-T-4476
Moxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4476 for delivery to the Navy Expeditionary Central Facility in Williamsburg, VA, with a required delivery window of 20 days. The contract specifies a total quantity of 24 bottles, each containing 30 tablets, with a unit price of $24.00 per bottle and no variance allowed in quantity. The product must comply with stringent packaging and labeling standards as defined by Medical Marking Standard No. 1, superseding MIL-STD-129, and must be shipped in commercial, durable containers that ensure safe transport via common carrier at the lowest cost. Shelf life is strictly limited to 36 months and non-extendable, with storage required at controlled room temperature and protection from high humidity. The item is regulated by the FDA, and bidders must provide full manufacturer details including NDC numbers, with TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC. identified as potential suppliers. All packaging, marking, and shipment must adhere to DLA’s Master List of Technical and Quality Requirements, and hazardous material provisions apply as per FED-STD-313 and ASTM D3951 where applicable. Shipment must be made by the fastest traceable means, excluding parcel post, and must be palletized per RP001 requirements. The contract mandates delivery FOB destination, with inspection and acceptance occurring upon receipt at the delivery point, and all documentation must reflect compliance with DLA’s unit of issue and procurement standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details